tetradecanoylphorbol acetate has been researched along with panobinostat in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bullen, CK; Durand, CM; Laird, GM; Siliciano, JD; Siliciano, RF | 1 |
| Hamam, HJ; Palaniyar, N | 1 |
2 other study(ies) available for tetradecanoylphorbol acetate and panobinostat
| Article | Year |
|---|---|
New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo.
Topics: Anti-HIV Agents; Azepines; Bryostatins; CD4-Positive T-Lymphocytes; Cell Cycle Proteins; Depsipeptides; Disulfiram; Histone Deacetylase Inhibitors; HIV Infections; HIV-1; Humans; Hydroxamic Acids; Indoles; Ionomycin; Lymphocyte Activation; Nuclear Proteins; Panobinostat; Tetradecanoylphorbol Acetate; Transcription Factors; Triazoles; Virus Latency; Vorinostat | 2014 |
Histone Deacetylase Inhibitors Dose-Dependently Switch Neutrophil Death from NETosis to Apoptosis.
Topics: Acetylation; Apoptosis; Cells, Cultured; Extracellular Traps; Histone Code; Histone Deacetylase Inhibitors; Histones; Humans; Hydroxamic Acids; Lipopolysaccharides; NADPH Oxidases; Neutrophils; Panobinostat; Reactive Oxygen Species; Sulfonamides; Tetradecanoylphorbol Acetate | 2019 |